Pseudomyxoma peritonei--a revisit: report of 2 cases and literature review

Chunyanca Li1, Rani Kanthan, S C Kanthan

  • 1Department of Pathology, Royal University Hospital, 103, Hospital Drive, Saskatoon, Saskatchewan, SK S7N OW8, Canada. chunyanca@yahoo.ca

Abstract

Insights

Pseudomyxoma peritonei (PMP) is a rare, challenging disease. This report details two PMP cases, highlighting its relapsing nature and the need for surgical vigilance with mucinous appendiceal neoplasms.

Area of Science:

  • Oncology
  • Gastroenterology
  • Surgical Pathology

Background:

  • Pseudomyxoma peritonei (PMP) is a rare, chronic, and poorly understood condition.
  • Characterized by disseminated mucinous ascites and peritoneal implants, PMP presents diagnostic challenges.
  • It follows a relapsing course, often with delayed diagnosis.

Purpose of the Study:

  • To present two cases of Pseudomyxoma peritonei (PMP).
  • To illustrate the two biological variants of PMP: disseminated peritoneal adenomucinosis (DPAM) and peritoneal mucinous carcinomatosis (PMCA).
  • To emphasize the challenges in managing recurrent PMP.

Main Methods:

  • Case report of two patients with Pseudomyxoma peritonei.
  • Detailed clinical course including diagnosis and management strategies.
  • Pathological review of both benign (DPAM) and malignant (PMCA) variants.

Main Results:

  • Both reported PMP cases exhibited multiple relapses and disease progression.
  • Despite aggressive management including surgery and chemotherapy, recurrence was observed.
  • The cases highlight the distinct biological behaviors of DPAM and PMCA variants.

Conclusions:

  • Pseudomyxoma peritonei (PMP) remains an enigmatic disease with a protracted clinical course.
  • Multiple recurrences are common despite optimal management.
  • Surgeons must be vigilant with mucinous neoplasms of the appendix, ensuring adequate excision and debridement due to PMP's potential as a delayed consequence.

Related Concept Videos